Abstract
Therapeutic proteins (TPs) have ranked among the most important and fastest-growing classes of drugs in the clinic, yet the development of successful TPs is often limited by unsatisfactory efficacy. Understanding pharmacokinetic (PK) characteristics of TPs is key to achieving sufficient and prolonged exposure at the site of action, which is a prerequisite for eliciting desired pharmacological effects. PK modeling represents a powerful tool to investigate factors governing in vivo disposition of TPs. In this mini-review, we discuss many state-of-the-art models that recapitulate critical processes in each of the absorption, distribution, metabolism/catabolism, and excretion pathways of TPs, which can be integrated into the physiologically-based pharmacokinetic framework. Additionally, we provide our perspectives on current opportunities and challenges for evolving the PK models to accelerate the discovery and development of safe and efficacious TPs.
| Original language | English |
|---|---|
| Pages (from-to) | 867-878 |
| Number of pages | 12 |
| Journal | Drug Metabolism and Disposition |
| Volume | 50 |
| Issue number | 6 |
| DOIs | |
| State | Published - Jun 1 2022 |
Fingerprint
Dive into the research topics of 'Mathematical Models to Characterize the Absorption, Distribution, Metabolism, and Excretion of Protein Therapeutics'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver